Gainers
- Avalo Therapeutics AVTX shares rose 26.5% to $0.12 during Tuesday's pre-market session. The company's market cap stands at $22.5 million.
- LumiraDx LMDX stock rose 22.88% to $0.11. The company's market cap stands at $35.2 million.
- Creative Medical Tech CELZ shares rose 16.77% to $4.99. The company's market cap stands at $7.1 million.
- Dermata Therapeutics DRMA stock increased by 15.51% to $0.67. The market value of their outstanding shares is at $2.1 million.
- Context Therapeutics CNTX stock moved upwards by 14.56% to $1.18. The company's market cap stands at $18.8 million.
- Tourmaline Bio TRML shares moved upwards by 14.54% to $17.01. The company's market cap stands at $3.3 billion.
Losers
- Kintara Therapeutics KTRA stock declined by 69.2% to $1.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.0 million.
- Galera Therapeutics GRTX shares decreased by 54.55% to $0.1. The company's market cap stands at $4.2 million.
- Sarepta Therapeutics SRPT stock fell 43.87% to $60.43. The company's market cap stands at $5.6 billion.
- Avenue Therapeutics ATXI shares fell 31.93% to $0.24. The market value of their outstanding shares is at $2.1 million.
- Sientra SIEN shares fell 20.55% to $1.16. The company's market cap stands at $13.0 million.
- Annovis Bio ANVS stock decreased by 17.8% to $6.7. The company's market cap stands at $60.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ATXIAvenue Therapeutics Inc
$1.80-0.01%
AVTXAvalo Therapeutics Inc
$8.91-1.87%
CELZCreative Medical Technology Holdings Inc
$2.4020.0%
CNTXContext Therapeutics Inc
$1.06-2.75%
DRMADermata Therapeutics Inc
$1.148.57%
GRTXGalera Therapeutics Inc
$0.1380-4.83%
SRPTSarepta Therapeutics Inc
$119.30-0.14%
TRMLTourmaline Bio Inc
$20.651.53%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in